Does RAVULIZUMAB-CWVZ Cause Lung neoplasm malignant? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Lung neoplasm malignant have been filed in association with RAVULIZUMAB-CWVZ. This represents 0.2% of all adverse event reports for RAVULIZUMAB-CWVZ.
15
Reports of Lung neoplasm malignant with RAVULIZUMAB-CWVZ
0.2%
of all RAVULIZUMAB-CWVZ reports
4
Deaths
3
Hospitalizations
How Dangerous Is Lung neoplasm malignant From RAVULIZUMAB-CWVZ?
Of the 15 reports, 4 (26.7%) resulted in death, 3 (20.0%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Lung neoplasm malignant Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST